tiprankstipranks
Advertisement
Advertisement

CHGCF Stock Latest News

Chugai’s SPYK04 Trial Completion: What It Means for CHGCF Investors
Company AnnouncementsChugai’s SPYK04 Trial Completion: What It Means for CHGCF Investors
18d ago
CHGCF
Chugai Pharmaceutical Earnings Call Highlights Growth Momentum
PremiumCompany Announcements
Chugai Pharmaceutical Earnings Call Highlights Growth Momentum
24d ago
Chugai Highlights FX Impact in Interim 2026 Financial Materials
PremiumCompany Announcements
Chugai Highlights FX Impact in Interim 2026 Financial Materials
24d ago
Chugai Pharmaceutical Delivers Strong First-Half 2026 Results and Confirms Full-Year Outlook
PremiumCompany Announcements
Chugai Pharmaceutical Delivers Strong First-Half 2026 Results and Confirms Full-Year Outlook
24d ago
Chugai Confirms H1 2026 Results Included in Roche Group Earnings
PremiumCompany Announcements
Chugai Confirms H1 2026 Results Included in Roche Group Earnings
26d ago
CHGCF Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsCHGCF Upcoming Earnings Report: What to Expect?
26d ago
Chugai’s Immunotherapy Combo Trial Reaches Completion: What the Latest Update Means for Investors
Premium
Company Announcements
Chugai’s Immunotherapy Combo Trial Reaches Completion: What the Latest Update Means for Investors
2M ago
CHGCF
Chugai Sets Terms for New Trust-Based Stock Compensation Plans
Premium
Company Announcements
Chugai Sets Terms for New Trust-Based Stock Compensation Plans
4M ago
Chugai Results Reflected in Roche’s First-Quarter 2026 Sales Report
PremiumCompany Announcements
Chugai Results Reflected in Roche’s First-Quarter 2026 Sales Report
4M ago
CHGCF Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CHGCF Earnings this Week: How Will it Perform?
4M ago
Chugai Clarifies Strategic Alliance and Governance Structure Under Roche Control
PremiumCompany Announcements
Chugai Clarifies Strategic Alliance and Governance Structure Under Roche Control
5M ago
Chugai Weighs Investment Unit Cut to Boost Liquidity and Broaden Investor Base
PremiumCompany Announcements
Chugai Weighs Investment Unit Cut to Boost Liquidity and Broaden Investor Base
5M ago
Chugai, Roche Halt Neuromuscular Trials of Emugrobart but Press On in Obesity
PremiumCompany AnnouncementsChugai, Roche Halt Neuromuscular Trials of Emugrobart but Press On in Obesity
5M ago
Chugai and Roche Advance NXT007 Into Phase III, Raising the Stakes in Hemophilia A
Premium
Company Announcements
Chugai and Roche Advance NXT007 Into Phase III, Raising the Stakes in Hemophilia A
5M ago
CHGCF
Chugai and Roche Advance NXT007 Into Phase III to Challenge Emicizumab in Hemophilia A
Premium
Company Announcements
Chugai and Roche Advance NXT007 Into Phase III to Challenge Emicizumab in Hemophilia A
5M ago
CHGCF
Chugai’s SAIL66 Phase I Completion: What the Latest Trial Update Means for Investors
PremiumCompany Announcements
Chugai’s SAIL66 Phase I Completion: What the Latest Trial Update Means for Investors
5M ago
CHGCF
Chugai to Replace Restricted Stock with Trust-Based Equity Incentive Plan
PremiumCompany Announcements
Chugai to Replace Restricted Stock with Trust-Based Equity Incentive Plan
7M ago
Chugai Pharmaceutical Plans Sharp Dividend Hike with 100th Anniversary Payout, Signals Normalization in 2026
PremiumCompany Announcements
Chugai Pharmaceutical Plans Sharp Dividend Hike with 100th Anniversary Payout, Signals Normalization in 2026
7M ago
Chugai’s 2025 Performance Reflected in Parent Roche’s Fiscal Results
PremiumCompany Announcements
Chugai’s 2025 Performance Reflected in Parent Roche’s Fiscal Results
7M ago
CHGCF Earnings this Week: How Will it Perform?
PremiumPre-EarningsCHGCF Earnings this Week: How Will it Perform?
7M ago
Chugai’s DONQ52 Celiac Study Advances, Adding a New Mid‑Stage Catalyst for CHGCF
Premium
Company Announcements
Chugai’s DONQ52 Celiac Study Advances, Adding a New Mid‑Stage Catalyst for CHGCF
7M ago
CHGCF
Chugai Pharmaceutical Completes Absorption-Type Merger of Renalys Pharma
Premium
Company Announcements
Chugai Pharmaceutical Completes Absorption-Type Merger of Renalys Pharma
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >